Halma buys Rovers Medical for €85m
Halma
2,725.00p
16:40 20/12/24
-0.29%
-8.00p
Health tech company Halma on Monday said it had bought Netherlands-based Rovers Medical Devices for €85m (£73m).
Electronic & Electrical Equipment
10,079.22
17:14 20/12/24
-0.01%
-1.07
FTSE 100
8,084.61
17:04 20/12/24
n/a
n/a
FTSE 350
4,463.29
17:14 20/12/24
n/a
n/a
FTSE All-Share
4,421.11
17:04 20/12/24
n/a
n/a
Rovers designs and makes sample collection devices used in the prevention and diagnostics of cervical cancer, Halma said in a statement. An extra payment of €6m is payable in cash, based on Rovers' performance in the period to March 31, 2025.
Unaudited revenue for the 12 months to 31 December 2023 was €12.0m, with return on sales more than double Halma's target range of 18-22%. Rovers will be a standalone company within Halma's Healthcare sector, led by its current management team, Halma added.
Reporting by Frank Prenesti for Sharecast.com